HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

B Parmentier Selected Research

Ligands

7/2008P53-mediated upregulation of DcR1 impairs oxaliplatin/TRAIL-induced synergistic anti-tumour potential in colon cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


B Parmentier Research Topics

Disease

1Gastroesophageal Reflux (GERD)
05/2013
1Phimosis
12/2012
1Necrosis
07/2008
1Neoplasms (Cancer)
07/2008
1Colorectal Neoplasms (Colorectal Cancer)
07/2008
1Colonic Neoplasms (Colon Cancer)
07/2008

Drug/Important Bio-Agent (IBA)

1Adrenal Cortex Hormones (Corticosteroids)IBA
12/2012
1Oxaliplatin (Eloxatin)FDA LinkGeneric
07/2008
1Small Interfering RNA (siRNA)IBA
07/2008
1LigandsIBA
07/2008

Therapy/Procedure

1Splenectomy
05/2013
1Therapeutics
07/2008
1Drug Therapy (Chemotherapy)
07/2008